Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years.

Bibliographic Details
Published in:PLOS Neglected Tropical Diseases
Main Authors: Piero L Olliaro, Annette C Kuesel, Christine M Halleux, Mark Sullivan, John C Reeder
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science (PLoS) 2018
Subjects:
Online Access:https://doi.org/10.1371/journal.pntd.0006837
https://doaj.org/article/a2bcdca835654a6a84ce56956c5cf6ea
Description
Description not available.